EP Lab

This channel includes news and new technology innovations for cardiac electrophysiology (EP) systems, techniques and devices. This includes implantable EP devices, pacemakers, ICD, CRT, ablation technologies, left atrial appendage occlusion (LAA), atrial fibrilation (AF) and Holter monitors.

Marijuana Use Does Not Increase Risk of Arrhythmias, Might Reduce AFib Risk. #HRS2018
News | Atrial Fibrillation | May 15, 2018

May 15, 2018 — According to new research, smoking marijuana may not be associated with an increased risk of...

First Results Reported from AVIATOR 2 Registry for AFib Patients Undergoing PCI.

Photo courtesy of the American Heart Association

News | Atrial Fibrillation | May 15, 2018

May 15, 2018 – Results of the AVIATOR 2 international registry data show a discrepancy between physician perception...

New Combined Risk Score More Effectively Predicts Stroke Risk in AFib Patients

Image courtesy of Intermountain Medical Center Heart Institute

News | Atrial Fibrillation | May 11, 2018

May 11, 2018 — A new ...

Cardiva Medical Announces Completion of the AMBULATE Pivotal Trial
News | Vascular Closure Devices | May 10, 2018

May 10, 2018 — Cardiva Medical Inc. announced the completion of the AMBULATE pivotal trial, one of several...

Online ECG Monitoring Detects Paroxysmal AFib More Effectively Than Holter, Patch Methods
News | ECG Monitoring Services | May 09, 2018

May 9, 2018 – Medicalgorithmics S.A. will present the results of a large...

The Angel Medical Systems' AngelMed Guardian System is an implantable cardiac monitor intended to detect and alert patients of a potential heart attack.

 The Angel Medical Systems' AngelMed Guardian System is an implantable cardiac monitor intended to detect and alert patients of a potential heart attack. 

Technology | Implantable Cardiac Monitor (ICM) | May 09, 2018

 May 9, 2018 — The U.S. Food and Drug Administration (FDA) said it recently granted market clearance for Angel...

Videos | Stroke | May 09, 2018

A new clinical trial at The Ohio State University Wexner Medical Center is examining an implanted device that uses...

The Vivistim device is similar to a pacemaker, which uses leads to electrically stimulate the brain. A new clinical trial at The Ohio State University Wexner Medical Center is examining use of this device for stroke rehabilitation.

A new clinical trial at The Ohio State University Wexner Medical Center is examining an implanted device that uses vagus nerve stimulation to help stroke patients regain motor function. The Vivistim device is similar to a pacemaker, which uses leads to electrically stimulate the brain. 

News | Stroke | May 09, 2018

May 9, 2018 — Stroke rehabilitation specialists at the The Ohio State University Wexner Medical Center are among the...

Biosense Webster Launches Carto Vizigo Bi-Directional Guidance Sheath
Technology | Ablation Systems | May 08, 2018

May 8, 2018 — Biosense Webster Inc. announced its Carto Vizigo Bi-directional Guiding Sheath is now available in the...

BardyDx CAM Ambulatory ECG Monitor Patch Detects More Arrhythmias in Head-to-Head Study
News | ECG Monitoring Services | May 08, 2018

May 8, 2018 — Bardy Diagnostics Inc. (BardyDx) announced that the American Heart Journal has published the results...

The U.S. Food and Drug Administration (FDA) has approved Portola Pharmaceuticals' Andexxa, the first antidote indicated for patients treated with rivaroxaban (Xarelto) and apixaban (Eliquis), when reversal of anticoagulation is needed due to life-threatening or uncontrolled bleeding.

The U.S. Food and Drug Administration (FDA) has approved Portola Pharmaceuticals' Andexxa, the first antidote indicated for patients treated with rivaroxaban (Xarelto) and apixaban (Eliquis), when reversal of anticoagulation is needed due to life-threatening or uncontrolled bleeding.

 

Feature | Antiplatelet and Anticoagulation Therapies | May 07, 2018

May 7, 2018 — The U.S. Food and Drug Administration (FDA) has approved Portola Pharmaceuticals' Andexxa, the first...

Stereotaxis and Acutus Medical Announce Strategic Collaboration
News | Ablation Systems | May 04, 2018

May 4, 2018 — Stereotaxis and Acutus Medical announced a strategic collaboration to integrate the Stereotaxis Niobe...

APN Health Releases Navik 3D Cardiac Mapping System
Technology | EP Mapping and Imaging Systems | May 03, 2018

May 3, 2018 — APN Health LLC announced its Navik 3D...

The Abbott Advisor HD Grid Mapping Catheter, Sensor Enabled, allows high density electro mapping for transcatheter EP cardiac ablation procedures.
Technology | EP Mapping and Imaging Systems | May 03, 2018

May 3, 2018 — The U.S. Food and Drug Administration (FDA) has granted market clearance for the Abbott Advisor HD...

Overlay Init